Table of Contents
CipherBio Weekly Digest: Week of Feb 3 – Feb 9, 2022
This week we bring you news and events about $2.77B in deals, $391.90M in Series A, 70 companies and 29 investors added to our CipherBio platform.
$2.77B
Deals
$391.90M
Series A
$324.2M
Series B
$506.3M
Later Rounds
$1.2B
M&A/IPOs
70
New Companies on CipherBio
Sign Up For Your Free Account ➜
Top Deals This Week
Seismic Therapeutic raises $101M in Series A round led by Lightspeed Venture Partners.
Endeavor BioMedicines raises $101M in Series B led by Ally Bridge Group and Avidity Partners. Also in Series B
ConcertoCare raises $105M led by Wells Fargo Strategic Capital.
Dewpoint Therapeutics gets $150M in Series C led by Softbank Vision Fund 2.
Ventus Therapeutics raises $140M / Series B led by Softbank Vision Fund 2 and RA Capital Management. In Series F
Lyra Health raises $235M led by Dragoneer Investment Group.
Company | Round | Amount |
---|---|---|
Series A | $101M | |
Series B | $101M | |
Series B | $105M | |
Series C | $150M | |
Series C | $140M | |
Series F | $235M |
This Week’s Lead Investors in Top Rounds
Lead investors this week are Lightspeed Venture Partners, Ally Bridge Group, Avidity Partners, Wells Fargo Strategic Capital, Softbank Vision Fund 2, RA Capital Management, Dragoneer Investment Group.
This Week in Clinical Phases
In phase 1 Synthekine announces trial of STK-012 for the treatment of solid tumors. Also,
Avacta Group announces a phase 1 trial of their product AVA6000. French-based
ImCheck Therapeutics starts phase 2 trial of their anti-BTN3A monoclonal antibody ICT01.
Acurx Pharmaceuticals starts their phase 2A trial of Ibezapolstat, their lead antibiotic candidate.
Nanoscope Therapeutics starts a phase 2B trial of MCO-010 for gene therapy to restore vision.
SaNOtize starts phase 3 trial of Nitric Oxide Nasal Spray (NONS) as an effective COVID-19 treatment.
BioCardia receives FDA Breakthrough Device for the CardiAMP cell therapy system.
Starfield, food & science technology, raised $100M in Series B round led by Primavera Capital Group, Lightspeed China Partners and Joy Capital.
FlipDish raised $100M in Series C led by Tencent. In AgTech
MycoWorks raised $125M in Series C to build a new alt-leather factory. WayCool raised $117M in Series D led by LightRock, LightBox, FMO and others.
70 Life Science Companies Added
This week we added 123 funding events, 70 life science companies and 29 investors.
To get all the latest life science deals and VC funding data delivered straight to your inbox weekly become a CipherBio PRO member.